Use of miRNAs in Growth Hormone Deficiency (GHD)

Summary

This study aims at improving knowledge about the diagnosis of growth hormone deficiency (GHD) and treatment with growth hormone (GH), with the goal of providing information on the presence of new biomarkers, such as miRNAs, for diagnostic and therapeutic purposes, with the goal of establishing a personalized GH treatment scheme, optimizing resources, reducing costs, and improving outcomes.

Conditions

• Growth Hormone Deficiency

Sponsors & Collaborators

• Azienda Ospedaliera Universitaria Policlinico "G. Martino"

  collaborator OTHER

• Ospedali Riuniti Ancona

  collaborator OTHER

• Federico II University

  collaborator OTHER

• Azienda Unita Sanitaria Locale di Piacenza

  collaborator OTHER

• Azienda Ospedaliero Universitaria Policlinico Modena

  collaborator OTHER

• Azienda USL Reggio Emilia - IRCCS

  collaborator OTHER_GOV

• Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

  collaborator OTHER

• Ospedali Riuniti di Foggia

  collaborator OTHER

• IRCCS Ospedale San Raffaele

  collaborator OTHER

• Università degli Studi del Piemonte Orientale Amedeo Avogadro

  collaborator OTHER

• IRCCS Azienda Ospedaliero-Universitaria di Bologna

  collaborator OTHER

• Istituto Auxologico Italiano

  collaborator OTHER

• OSPEDALE CARLO POMA ASST MANTOVA

  collaborator UNKNOWN

• University of Campania Luigi Vanvitelli

  collaborator OTHER

• Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

  collaborator OTHER

• University of Parma

  lead OTHER

Principal Investigators

• Maria E Street, MD, PhD · University of Parma

Eligibility

Min Age

2 Years

Max Age

15 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-04-13

Primary Completion

2025-03-31

Completion

2026-03-01

Countries

• Italy

Study Locations